- Regeneron Pharmaceuticals (REGN +8.2%) is up on more than a 5x surge volume in apparent response to the use of its COVID-19 antibody cocktail, REGN-COV2, to treat President Trump who apparently plans to leave the hospital today.
- The President also received Gilead Sciences' (GILD +2.9%) Veklury (remdesivir) and dexamethasone as part his treatment.
- https://seekingalpha.com/news/3619913-regeneron-up-8-after-trump-treated-covidminus-19-antibody-cocktail
Monday, October 5, 2020
Regeneron up 8% after Trump treated with COVID-19 antibody cocktail
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.